SPOTLIGHT: Neuro-Hitech completes merger deal


Neuro-Hitech has completed a deal to merge with New York-based Q-RNA. Q-RNA is developing a series of novel compounds that target beta amyloid (A-beta) and are designed to halt or reverse Alzheimer's disease caused by A-beta. Release